InsidersTradesSigma
Hamlet BioPharma AB: insider trades · Finland · FIN-FSA
FI:hamlet-biopharma-abSE0015661152FI·FIN-FSAMcap 1.4Bn€Healthcare
Discover the full insider trade history of Hamlet BioPharma AB, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Hamlet BioPharma AB has published 1 reports. Market capitalisation: €1.4bn. The latest transaction was filed on 29 March 2026 — Purchase. Among the most active insiders: Marianne Catharina Svanborg. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
€16,127
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended June 2025 · cache
7.50 €
Analyst consensus
Income statement
Net income−54.7 M€0.0% margin
Valuation
P/Book35.9x
Beta0.31
Balance sheet & cash
Market cap1.38 Bn€
Free Cash Flow−38.9 M€
Profitability & ownership
ROE-106.2%
ROA-59.8%
Last declaration on 29 March 2026
Declarations1 total
Executives●Purchase16FIN-FSA
€16,12725,000 shares@ €0.64510.0012% mcap100.0% of flow
Aktie
FI:A003X421-1·
Ideal exit: 21 Dec 2026 (T+270)
1 of 1 declaration